<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="mitral valve regurgitation severity in dogs with stage B2 myxomatous" exact="mitral valve disease" post="– A pilot study 16.10‐16.25 ESVC‐O‐2 Ward Retrospective evaluation"/>
 <result pre="tolerability of pimobendan in cats with obstructive versus nonobstructive hypertrophic" exact="cardiomyopathy" post="16.25‐16.40 ESVC‐O‐3 Crosara Aorto‐septal angle, isolated basal septal hypertrophy"/>
 <result pre="of noninvasively determined pulmonary artery pressure in dogs with myxomatous" exact="mitral valve disease" post="(MMVD) 11.35‐11.50 ESVC‐O‐5 Ksiazek Left atrial tear in dogs"/>
 <result pre="11.35‐11.50 ESVC‐O‐5 Ksiazek Left atrial tear in dogs with myxomatous" exact="mitral valve disease" post="‐ clinical presentation, echocardiographic features and long‐term survival 11.50‐12.05"/>
 <result pre="systolic function before and 24 hours after percutaneous closure of" exact="patent ductus arteriosus" post="in 120 dogs 12.05‐12.20 ESVC‐O‐7 Adin Delayed Electrolyte Depletion"/>
 <result pre="wall thickness, Troponin‐I and IGF‐1 in cats with asymptomatic hypertrophic" exact="cardiomyopathy" post="14.40‐14.55 ESVC‐O‐11 Patata Biomarker discovery in cats with cardiomyopathy"/>
 <result pre="hypertrophic cardiomyopathy 14.40‐14.55 ESVC‐O‐11 Patata Biomarker discovery in cats with" exact="cardiomyopathy" post="14.55‐15.10 ESVC‐O‐12 Hanås Blood pressure measurement by High Definition"/>
 <result pre="Busato Does pleural effusion protect against arterial thromboembolism in feline" exact="congestive heart failure?" post="15.25‐15.40 ESVC‐O‐14 Ferasin Iatrogenic heart murmur: a new cause"/>
 <result pre="Supraventricular tachycardia in 23 cats; comparison with 21 cats with" exact="atrial fibrillation" post="(2004‐2014) 17.00‐17.15 ESVC‐O‐18 Perego Electrocardiographic patterns of ventricular pre‐excitation"/>
 <result pre="reoccurrence of congestive signs in dogs with ACVIM‐Stage C myxomatous" exact="mitral valve disease" post="(MMVD) SCH – Society of Comparative Hepatology Thursday 19"/>
 <result pre="dehydrogenase as a prognostic marker for nodal diffuse large B‐cell" exact="lymphoma" post="in dogs 12.20‐12.35 ESVCP‐O‐2 Prasinou The paradigm of erythrocyte"/>
 <result pre="relationship between ionised and total calcium in dogs with ionised" exact="hypercalcaemia" post="14.55‐15.10 ESVCP‐O‐6 Dewhurst The effect of boric acid on"/>
 <result pre="readings in out‐patient and in‐patient dogs 15.10‐15.25 ESVNU‐O‐4 Rossi Immune‐complex" exact="glomerulonephritis" post="in cats: a retrospective study based on clinico‐pathological data"/>
 <result pre="to an E. coli probiotic as a potential therapeutic for" exact="urinary tract infection" post="15.55‐16.10 ESVNU‐O‐7 Baumgartner Prognostic factors in dogs with common"/>
 <result pre="ESVNU‐O‐7 Baumgartner Prognostic factors in dogs with common causes of" exact="proteinuria" post="16.10‐16.25 ESVNU‐O‐8 Bijsmans The effect of dietary sodium on"/>
 <result pre="relative supersaturation (CaOx RSS) in dogs 16.25‐16.40 ESVNU‐O‐9 Caccamo Proliferative" exact="urethritis" post="in dogs: long‐term follow up and prognosis ISCAID ‐"/>
 <result pre="A retrospective multi‐centre study on treatment and outcome in disseminated" exact="aspergillosis" post="in 41 dogs 14.25‐14.40 ISCAID‐O‐7 Cervone Canine Trichuris vulpis"/>
 <result pre="fecal microbiota and unconjugated fecal bile acids in dogs with" exact="diabetes mellitus" post="10.00‐10.15 ESCG‐O‐2 Stavroulaki Impact of antibiotic administration on fecal"/>
 <result pre="Sanchez Fecal microbial metabolism is altered in dogs with chronic" exact="enteropathy" post="11.20‐11.35 ESCG‐O‐4 Swales The pug breed demonstrates a worse"/>
 <result pre="pug breed demonstrates a worse response to treatment of protein‐losing" exact="enteropathy" post="than other breeds of dog 11.35‐11.50 ESCG‐O‐5 Petrelli Is"/>
 <result pre="healthy dogs 12.20‐12.35 ESCG‐O‐8 Kaufmann Long‐term consequences of acute hemorrhagic" exact="diarrhea" post="syndrome in dogs ESVIM – European Society of Veterinary"/>
 <result pre="17.15‐17.30 ESVIM‐O‐4 Jaffey Serum 25‐hydroxyvitamin D in dogs with sinonasal" exact="aspergillosis" post="17.30‐17.45 ESVIM‐O‐5 Jaffey Plasma mRNA cathelicidin expression in hospitalized"/>
 <result pre="expression in hospitalized critically ill dogs 17.45‐18.00 ESVIM‐O‐6 Jaffey Hereditary" exact="methemoglobinemia" post="in dogs caused by cytochrome b5 reductase deficiency associated"/>
 <result pre="shedding of amyloid fibrils 17.30‐17.45 ESVIM‐O‐11 Rabozzi Treatment of non‐lactate" exact="metabolic acidosis" post="in hypovolemic and normovolemic dogs: chloride‐free iso‐osmolar solution with"/>
 <result pre="is a valuable treatment option for dogs and cats with" exact="cancer" post="after failing first line therapy 14.55‐15.10 ESVONC‐O‐3 Borgatti Impact"/>
 <result pre="Hemangiosarcoma 15.10‐15.25 ESVONC‐O‐4 Škor Humoral hypercalcemia of malignancy in canine" exact="lymphoma" post="WHO types and its impact on survival 15.25‐15.40 ESVONC‐O‐5"/>
 <result pre="(MHC) class II haplotypes associated with increased risk of canine" exact="diabetes mellitus" post="– a breed‐specific study 10.30‐10.45 ESVE‐O‐7 Copley Comparison of"/>
 <result pre="Whole Genome Sequencing to explore genetic risk factors in canine" exact="diabetes mellitus" post="12.20‐12.35 ESVE‐O‐12 Linari Evaluation of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid ‐"/>
 <result pre="of follicular‐cell thyroid carcinoma: a novel canine model for translational" exact="thyroid cancer" post="research ESVCN – European Society of Veterinary Comparative Nutrition"/>
 <result pre="follicular‐cell thyroid carcinoma: a novel canine model for translational thyroid" exact="cancer" post="research ESVCN – European Society of Veterinary Comparative Nutrition"/>
 <result pre="Heart rate variability of dogs in various stages of degenerative" exact="mitral valve disease" post="ESVC‐P‐2 van Israel Comparison of serum digoxin concentrations from"/>
 <result pre="rate assessed by 2‐dimensional speckle tracking echocardiography in dogs with" exact="pulmonary hypertension" post="ESVC‐P‐4 Lee Potential renoprotective effect of angiotensin‐receptor antagonists in"/>
 <result pre="Potential renoprotective effect of angiotensin‐receptor antagonists in dogs with myxomatous" exact="mitral valve disease" post="ESVC‐P‐5 Takamura Perioperative management with peripheral arteries in dogs"/>
 <result pre="concentration, renal function and survival in 85 dogs with acute" exact="congestive heart failure" post="ESVC‐P‐7 Yilmaz Platelet proteomic profile in dogs with heart"/>
 <result pre="desmin aggregates consistent with intermediate filament dysfunction in feline hypertrophic" exact="cardiomyopathy" post="ESVC‐P‐10 Guglielmini Prevalence and risk factors for atrial fibrillation"/>
 <result pre="feline hypertrophic cardiomyopathy ESVC‐P‐10 Guglielmini Prevalence and risk factors for" exact="atrial fibrillation" post="in dogs with myxomatous mitral valve disease ESVC‐P‐11 Poissonnier"/>
 <result pre="and risk factors for atrial fibrillation in dogs with myxomatous" exact="mitral valve disease" post="ESVC‐P‐11 Poissonnier Left atrial volume assessment in 160 Cavalier"/>
 <result pre="in 160 Cavalier King Charles Spaniels with and without degenerative" exact="mitral valve disease" post="(2017‐2019) ESVC‐P‐12 Passavin Hematological abnormalities in dogs with congenital"/>
 <result pre="of torasemide as a second line diuretic in dogs with" exact="congestive heart failure" post="ESVC‐P‐15 Mazzoldi Echocardiographic predictors of first onset of atrial"/>
 <result pre="heart failure ESVC‐P‐15 Mazzoldi Echocardiographic predictors of first onset of" exact="atrial fibrillation" post="in dogs with myxomatous mitral valve disease ESVC‐P‐16 Romito"/>
 <result pre="of first onset of atrial fibrillation in dogs with myxomatous" exact="mitral valve disease" post="ESVC‐P‐16 Romito Usefulness of Holter‐derived Lorenz plots analysis to"/>
 <result pre="effect of long flightprolonged air travel on dogs with heart" exact="mitral valve disease" post="ESVC‐P‐26 Lekane Clinical, ECG and echocardiographic findings in a"/>
 <result pre="in enteropathic cats ESVCP‐P‐6 Gori C‐Reactive Protein/Albumin ratio in canine" exact="acute pancreatitis" post="ESVCP‐P‐7 Navarro Martínez Urine capillary electrophoresis reference intervals for"/>
 <result pre="enteropathic cats ESVCP‐P‐6 Gori C‐Reactive Protein/Albumin ratio in canine acute" exact="pancreatitis" post="ESVCP‐P‐7 Navarro Martínez Urine capillary electrophoresis reference intervals for"/>
 <result pre="Pierini Platelet abnormalities and platelet‐to‐lymphocyte ratio (PLR) in canine immunosuppressant‐responsive" exact="enteropathy" post="(IRE): a retrospective study on 41 patients ESVCP‐P‐10 Galizzi"/>
 <result pre="immunosorbent assay (ELISA) in healthy dogs and dogs with myxomatous" exact="mitral valve disease" post="ESVNU – European Society of Veterinary Nephrology and Urology"/>
 <result pre="dogs ESVNU‐P‐7 Gori Evaluation of symmetric dimethylarginine (SDMA) in canine" exact="acute pancreatitis" post="ESVNU‐P‐8 From Evaluation of a point‐of‐care lateral flow immunoassay"/>
 <result pre="ESVNU‐P‐7 Gori Evaluation of symmetric dimethylarginine (SDMA) in canine acute" exact="pancreatitis" post="ESVNU‐P‐8 From Evaluation of a point‐of‐care lateral flow immunoassay"/>
 <result pre="acute uraemia managed with haemodialysis ESVNU‐P‐10 Pantaleo Risk factors for" exact="urinary tract infection" post="in dogs with natural occurring leptospirosis: a retrospective cohort"/>
 <result pre="in the diagnosis of renal disease in dogs affected with" exact="leishmaniasis" post="ESVNU‐P‐14 Zambarbieri Complicated UTI in dogs: uropathogens, antimicrobial resistance"/>
 <result pre="free‐roaming cats ISCAID‐P‐11 Walker Retrospective analysis of cases tested for" exact="leptospirosis" post="at a university teaching hospital ISCAID‐P‐12 Guzmán Ramos Canine"/>
 <result pre="and histopathological lesions in relation to outcomes in canine immunosuppressant‐responsive" exact="enteropathy" post="(Ire): prospective analysis in 57 dogs ESCG‐P‐2 Tabar Prevalence"/>
 <result pre="cPL, the severity of disease and mortality in suspected canine" exact="acute pancreatitis" post="ESCG‐P‐5 Candido Gastric mucosal pathology in Belgian Shepherd dogs"/>
 <result pre="the severity of disease and mortality in suspected canine acute" exact="pancreatitis" post="ESCG‐P‐5 Candido Gastric mucosal pathology in Belgian Shepherd dogs"/>
 <result pre="ESCG‐P‐9 Benvenuti Neutrophil‐to‐lymphocyte ratio (NLR) in canine patients with immunosuppressant‐responsive" exact="enteropathy" post="(IRE) ESCG‐P‐10 Ambrosini A Novel Canine‐Specific Model System to"/>
 <result pre="ESCG‐P‐13 Crisi The erythrocyte membrane lipidome in dogs with chronic" exact="enteropathy" post="ESCG‐P‐14 Da Riz Hypercobalaminaemia and its possible association with"/>
 <result pre="Weiß Serum Vitamin A and E concentrations in dogs with" exact="pancreatitis" post="ESCG‐P‐18 Galiazzo Water immersion vs gas insufflation in canine"/>
 <result pre="in the diagnosis of acid‐base basalnce disturbances in cats with" exact="chronic kidney disease" post="(CKD) ESVIM‐P‐5 Schulz Evaluation of different cleaning methods for"/>
 <result pre="or high plasma homocysteine concentration ESVIM‐P‐12 Gianesini Association between immune‐mediated" exact="hemolytic anemia" post="(IMHA) and acute pancreatitis in dogs ESVIM‐P‐13 Easley Evaluation"/>
 <result pre="high plasma homocysteine concentration ESVIM‐P‐12 Gianesini Association between immune‐mediated hemolytic" exact="anemia" post="(IMHA) and acute pancreatitis in dogs ESVIM‐P‐13 Easley Evaluation"/>
 <result pre="concentration ESVIM‐P‐12 Gianesini Association between immune‐mediated hemolytic anemia (IMHA) and" exact="acute pancreatitis" post="in dogs ESVIM‐P‐13 Easley Evaluation of Serum Procalcitonin in"/>
 <result pre="ESVIM‐P‐12 Gianesini Association between immune‐mediated hemolytic anemia (IMHA) and acute" exact="pancreatitis" post="in dogs ESVIM‐P‐13 Easley Evaluation of Serum Procalcitonin in"/>
 <result pre="Greci A statistical analysis to predict persistence of canine sinonasal" exact="aspergillosis" post="at endoscopic follow‐up by comparing three different scoring systems:"/>
 <result pre="in healthy dogs of different breeds ESVIM‐P‐23 Peano Canine sino‐nasal" exact="aspergillosis" post="in Italy (38 cases) ESVONC – European Society of"/>
 <result pre="in the dog ESVONC‐P‐2 Thumser‐Henner Sensitivity of canine and human" exact="cancer" post="cell lines towards thermoradiotherapy ESVONC‐P‐3 Lanore Interest of the"/>
 <result pre="of hepatic infiltration in case of nodal diffuse large B‐cell" exact="lymphoma" post="(DLBLCL) ESVONC‐P‐5 Campigli Pet owner feedback on psychological support"/>
 <result pre="effects of a single dose of vincristine in dogs with" exact="lymphoma" post="ESVE – European Society of Veterinary Endocrinology ESVE‐P‐1 Codea"/>
 <result pre="state and analytical method ESVE‐P‐7 Canonne‐Guibert Survival in cats with" exact="diabetes mellitus" post="and chronic pancreatitis: a preliminary study of 36 cases"/>
 <result pre="once daily Protamine Zinc Recombinant Human Insulin (ProZinc®) in canine" exact="diabetes mellitus" post="ESVE‐P‐9 Garcia Brachycephalic morphotype and pituitary tumor size in"/>
 <result pre="inflammatory response syndrome (SIRS) ESVE‐P‐11 Nerhagen Prednisolone induced hyperglycaemia and" exact="diabetes mellitus" post="in cats ESVE‐P‐12 Malerba Accuracy and precision of insulin"/>
 <result pre="fecal microbiota and unconjugated fecal bile acids in dogs with" exact="diabetes mellitus" post="B. Ruggerone 1, A.C. Manchester 2, F. del Baldo"/>
 <result pre="bile acid (BA) concentrations have been associated with type 1" exact="diabetes mellitus" post="(DM) in people. DM in dogs resembles human type"/>
 <result pre="ESCG‐O‐3 Fecal microbial metabolism is altered in dogs with chronic" exact="enteropathy" post="S. Bermudez Sanchez 1, R. Pilla 1, A. Gramenzi"/>
 <result pre="collected from 14 healthy dogs and 20 dogs with chronic" exact="enteropathy" post="(CE). Fecal DNA was extracted using a commercial kit"/>
 <result pre="pug breed demonstrates a worse response to treatment of protein‐losing" exact="enteropathy" post="than other breeds of dog H. Swales 1, D.J."/>
 <result pre="period, was selected for comparison. PLE was defined as any" exact="gastrointestinal disease" post="resulting in serum albumin below the laboratory reference interval"/>
 <result pre="cobalamin. Traditionally, their combination has been used to differentiate intestinal" exact="malabsorption" post="from dysbiosis. Despite the fact that the diagnostic and"/>
 <result pre="subgroups of food‐ (FRE), antibiotic‐ (ARE), steroid‐responsive (SRE) or protein‐losing" exact="enteropathy" post="(PLE), no difference in SF values was observed (ANOVA,"/>
 <result pre="tachypnea (RR &amp;gt; 40), hyper or hypothermia (T &amp;gt; 39.0°C or &amp;lt; 37.5°C), leucocytosis (WBC &amp;gt; 18*10 9/L)," exact="leukopenia" post="(WBC &amp;lt; 5*10 9/L, band neutrophilia and/or hypoglycaemia [glucose &amp;lt;4 mmol/L]) were"/>
 <result pre="No disclosures to report. ESCG‐O‐8 Long‐term consequences of acute hemorrhagic" exact="diarrhea" post="syndrome in dogs E. Kaufmann 1, K. Busch 1,"/>
 <result pre="this study was to evaluate, whether dogs with acute hemorrhagic" exact="diarrhea" post="syndrome (AHDS) have a higher prevalence of chronic enteropathies"/>
 <result pre="A historical control group of 67 dogs without history of" exact="gastroenteritis" post="was included to enable risk assessment. Dog owners were"/>
 <result pre="AHDS do not have an increased risk for developing chronic" exact="gastrointestinal disease" post="later in life, which is different to the risk"/>
 <result pre="mitral valve regurgitation severity in dogs with stage B2 myxomatous" exact="mitral valve disease" post="‐ A pilot study O. Belachsen, J. Sargent, T."/>
 <result pre="T. Wagner Southern Counties Veterinary Specialists, Ringwood, United Kingdom Myxomatous" exact="mitral valve disease" post="(MMVD) is associated with failure of the mitral valve"/>
 <result pre="dogs, MV regurgitation volume was calculated by subtracting the forward" exact="stroke" post="volume (Aortic outflow velocity time integral multiplied by the"/>
 <result pre="the aortic cross‐sectional area) from the total left ventricular (LV)" exact="stroke" post="volume (End‐systolic LV volume subtracted from the end‐diastolic LV"/>
 <result pre="calculated as the percentage of regurgitation volume from the total" exact="stroke" post="volume. Paired Student t‐test and Wilcoxon Signed‐Rank Test were"/>
 <result pre="significantly lower (p &amp;lt; 0.01) compared with baseline (43.7 +/− 4.7), forward" exact="stroke" post="volume was significantly increased ( P = 0.015), while"/>
 <result pre="volume was significantly increased ( P = 0.015), while total" exact="stroke" post="volume did not change significantly. This study suggests that"/>
 <result pre="tolerability of pimobendan in cats with obstructive versus nonobstructive hypertrophic" exact="cardiomyopathy" post="J.L. Ward 1, E. Kussin 2, M.A. Tropf 1,"/>
 <result pre="Pimobendan is frequently used off‐label for treatment of cats with" exact="congestive heart failure" post="(CHF) secondary hypertrophy cardiomyopathy (HCM). Concerns exist regarding the"/>
 <result pre="treatment of cats with congestive heart failure (CHF) secondary hypertrophy" exact="cardiomyopathy" post="(HCM). Concerns exist regarding the safety of pimobendan in"/>
 <result pre="cats with HOCM were more likely to manifest CHF as" exact="pulmonary edema" post="(44/47 versus 32/47; P = 0.003) and less likely to"/>
 <result pre="this study suggest that pimobendan is well‐tolerated in cats with" exact="cardiomyopathy" post="and CHF, regardless of presence of dynamic outflow tract"/>
 <result pre="of noninvasively determined pulmonary artery pressure in dogs with myxomatous" exact="mitral valve disease" post="(MMVD) G. Menciotti 1, M. Borgarelli 1, M. Aherne"/>
 <result pre="of Veterinary Medicine, Gainesville, United States of America Development of" exact="pulmonary hypertension" post="is an independent predictor of poor outcome in dogs"/>
 <result pre="this abstract. ESVC‐O‐5 Left atrial tear in dogs with myxomatous" exact="mitral valve disease" post="‐ clinical presentation, echocardiographic features and long‐term survival A.A."/>
 <result pre="(LAT) is an acute, life‐threatening, rare complication in canine myxomatous" exact="mitral valve disease" post="(MMVD). This case‐control matched multicenter retrospective study focussed on"/>
 <result pre="LAT diagnosis (time 0, T0) and at the resolution of" exact="pericardial effusion" post="(time 1, T1). Control dogs with similarly advanced MMVD"/>
 <result pre="without LAT. In both groups, 9 dogs were in ACVIM" exact="congestive heart failure" post="stage C and 6 in B2 MMVD. Commonly observed clinical"/>
 <result pre="and systolic function before and 24 hours after percutaneous closure of" exact="patent ductus arteriosus" post="in 120 dogs M. Claretti 1, D. Piantedosi 2,"/>
 <result pre="changes on left ventricular volumes before and 24‐hours after the" exact="patent ductus arteriosus" post="(PDA) occlusion by ACDO using standard echocardiography. The animals"/>
 <result pre="America Intravenous furosemide is the mainstay of treatment for acute" exact="congestive heart failure" post="in dogs, however, the potential for delayed effects on"/>
 <result pre="of dogs presented to the R(D)SVS: healthy (n = 18)," exact="chronic kidney disease" post="(CKD; IRIS stages 2‐4; serum creatinine 257 μmol/l, IQR395; n"/>
 <result pre="marked increase in UET‐1 excretion in dogs with stage C" exact="heart disease" post="(0.69,IQR 1.61 pg/mg; n = 11) compared to healthy dogs"/>
 <result pre="= 0.02). UET‐1 excretion was also increased in stage B2" exact="heart disease" post="(0.25 pg/mg, IQR 1.70; P = 0.03; n = 19)"/>
 <result pre="chronic disease (0.02 ng/mg, IQR 0.07), and none at all in" exact="heart disease" post="stages B1‐C. Renal ET‐1 activity increases with congestive heart"/>
 <result pre="in heart disease stages B1‐C. Renal ET‐1 activity increases with" exact="congestive heart failure," post="but surprisingly, also increases in MMVD before congestion develops."/>
 <result pre="different to those in isolated CKD and the development of" exact="congestive heart failure." post="Disclosures No disclosures to report. ESVC‐O‐9 High grade AV"/>
 <result pre="Connolly Royal Veterinary College, Potters Bar, United Kingdom Third degree" exact="atrioventricular block" post="(AVB) is characterised by complete atrioventricular (AV) dissociation, causing"/>
 <result pre="ventricular hypertrophy (17), chamber dilation (12); 13 cats presented with" exact="congestive heart failure" post="(CHF). Forty‐five cats had one or more comorbidities, the"/>
 <result pre="cats had one or more comorbidities, the most common were" exact="hyperthyroidism" post="(16), diabetes mellitus (9), azotaemia (8). Fifteen cats underwent"/>
 <result pre="one or more comorbidities, the most common were hyperthyroidism (16)," exact="diabetes mellitus" post="(9), azotaemia (8). Fifteen cats underwent epicardial pacemaker implantation,"/>
 <result pre="wall thickness, Troponin‐I and IGF‐1 in cats with asymptomatic hypertrophic" exact="cardiomyopathy" post="I. van Hoek 1, H. Hodgkiss‐Geere 2, E. Bode"/>
 <result pre="and echocardiographic parameters in forty‐four client‐owned cats with asymptomatic hypertrophic" exact="cardiomyopathy" post="(aHCM). Cats with diastolic interventricular septum (IVSd) and/or left"/>
 <result pre="by Royal Canin SAS. ESVC‐O‐11 Biomarker discovery in cats with" exact="cardiomyopathy" post="V. Patata 1, L. Carangiu 2, S. Pisanu 2,"/>
 <result pre="in the last decade, assays to measure circulating biomarkers of" exact="heart disease," post="such as cardiac troponin I and N‐terminal pro‐brain natriuretic"/>
 <result pre="proteins that may improve the identification of cats affected by" exact="cardiomyopathy" post="using biomarker discovery. Client‐owned cats were prospectively enrolled. Evaluation"/>
 <result pre="on diagnosis, cats were allocated to 5 groups, namely symptomatic" exact="cardiomyopathy" post="with signs of congestive heart failure (group CM‐Sx), asymptomatic"/>
 <result pre="allocated to 5 groups, namely symptomatic cardiomyopathy with signs of" exact="congestive heart failure" post="(group CM‐Sx), asymptomatic cardiomyopathy (group CM‐aSx), respiratory diseases (group"/>
 <result pre="cardiomyopathy with signs of congestive heart failure (group CM‐Sx), asymptomatic" exact="cardiomyopathy" post="(group CM‐aSx), respiratory diseases (group Resp‐Ds), systemic diseases without"/>
 <result pre="and 27 in Healthy. In CM‐Sx, 7/9 cats had hypertrophic" exact="cardiomyopathy" post="and 2/9 restrictive cardiomyopathy; lung edema was identified in"/>
 <result pre="Healthy. In CM‐Sx, 7/9 cats had hypertrophic cardiomyopathy and 2/9" exact="restrictive cardiomyopathy;" post="lung edema was identified in 7, pleural effusion and"/>
 <result pre="ESVC‐O‐13 Does pleural effusion protect against arterial thromboembolism in feline" exact="congestive heart failure?" post="F. Busato 1, A. Zoia 1, M. Drigo 2"/>
 <result pre="pleural effusion of any type or with ascites secondary to" exact="congestive heart failure" post="(CHF) show an enhanced systemic fibrinolysis, which may decreases"/>
 <result pre="without pleural effusion. Cross‐sectional study retrospectively evaluating client‐owned cats with" exact="heart disease" post="presented between 2004 and 2018. All cats included underwent"/>
 <result pre="divided into 3 groups: without CHF (group 1), with cardiogenic" exact="pulmonary edema" post="(group 2) and with pleural effusion (group 3). Frequency"/>
 <result pre="identifying patients requiring hospitalization or at risk of decompensation. Degenerative" exact="mitral valve disease" post="(DMVD) is the most common acquired canine cardiac disease."/>
 <result pre="parameters evaluated via POCUS at different ACVIM stages of degenerative" exact="mitral valve disease" post="in dogs. Echocardiographic and CVC POCUS findings of dogs"/>
 <result pre="administration of diuretics were recorded. Dogs with significant right sided" exact="heart disease" post="or pericardial effusion were excluded. POCUS CVC Cineloops were"/>
 <result pre="were recorded. Dogs with significant right sided heart disease or" exact="pericardial effusion" post="were excluded. POCUS CVC Cineloops were obtained during the"/>
 <result pre="LV dimensions were regressed against LA:Ao in 82 dogs with" exact="mitral valve disease." post="Systolic and diastolic LV volume estimates obtained by the"/>
 <result pre="LV volume index increased with increasing LA:Ao in dogs with" exact="mitral valve disease" post="( r = 0.28). Data provided by all investigators appeared"/>
 <result pre="Supraventricular tachycardia in 23 cats; comparison with 21 cats with" exact="atrial fibrillation" post="(2004‐2014) V.F.J. Greet 1, J.M.C. Sargent 2, M. Brannick"/>
 <result pre="predisposing factors and natural course of supraventricular tachycardia (SVT) and" exact="atrial fibrillation" post="(AF) are well described in people and to a"/>
 <result pre="presence of ventricular arrhythmia, left atrial diameter, heart rate and" exact="congestive heart failure" post="status on cardiac death. Differences in survival between groups"/>
 <result pre="2/10 radiographs. Echocardiographic examination disclosed RAA in 4/10 dogs with" exact="pulmonary hypertension." post="The bodyweights of dogs with RAA were significantly lower"/>
 <result pre="are necessary to assess a possible relationship between RAA and" exact="pulmonary hypertension." post="Disclosures No disclosures to report. ESVC‐O‐21 Predictors of reoccurrence"/>
 <result pre="reoccurrence of congestive signs in dogs with ACVIM‐Stage C myxomatous" exact="mitral valve disease" post="(MMVD) A. Franchini 1, J. Abbott 1, B. Tyrrell"/>
 <result pre="Clements, M. Coyne IDEXX, Westbrook, United States of America Iatrogenic" exact="hypothyroidism" post="in cats is associated with reduced glomerular filtration rate,"/>
 <result pre="percentage of cats with subnormal TT4 attributed to overtreatment of" exact="hyperthyroidism" post="have abnormal renal biomarkers as compared to those that"/>
 <result pre="hypothyroidism. The identified association of reduced renal function with iatrogenic" exact="hypothyroidism" post="emphasizes the importance of avoiding overtreatment. Comprehensive renal monitoring"/>
 <result pre="healthy cats and 25 cats with OD (9 cats with" exact="diabetes mellitus;" post="5 with hyperthyroidism; 3 each with chronic kidney disease,"/>
 <result pre="cats with diabetes mellitus; 5 with hyperthyroidism; 3 each with" exact="chronic kidney disease," post="or gastrointestinal disease; 2 with acute kidney injury; and"/>
 <result pre="5 with hyperthyroidism; 3 each with chronic kidney disease, or" exact="gastrointestinal disease;" post="2 with acute kidney injury; and 1 each with"/>
 <result pre="(MHC) class II haplotypes associated with increased risk of canine" exact="diabetes mellitus" post="‐ a breed‐specific study A. Denyer 1, J.M. Massey"/>
 <result pre="Manchester, United Kingdom, 3Royal Veterinary College, London, United Kingdom Canine" exact="diabetes mellitus" post="(DM) can be classified as insulin resistance or insulin"/>
 <result pre="laboratory and in‐clinic immunoassays are commonly used. The pathogenesis of" exact="hypothyroidism" post="may result in endogenous T4 cross‐reacting antibodies (T4AA) in"/>
 <result pre="Glycemic variability (GV) refers to glycemic excursions with episodes of" exact="hypoglycemia" post="and hyperglycemia throughout the day or on different days"/>
 <result pre="(GV) refers to glycemic excursions with episodes of hypoglycemia and" exact="hyperglycemia" post="throughout the day or on different days with no"/>
 <result pre="to be an indicator of glycemic control. In humans with" exact="diabetes mellitus" post="(DM), adding a glucagon‐like peptide‐1 (GLP‐1) analogue to the"/>
 <result pre="is a potentially valuable tool in the monitoring of canine" exact="diabetes mellitus." post="Disclosures Disclosures to report. Federico Fracassi Financial support: Dechra,"/>
 <result pre="Whole Genome Sequencing to explore genetic risk factors in canine" exact="diabetes mellitus" post="L.J. Davison 1, M.D. Wallace 1, A. Denyer 1,"/>
 <result pre="United States of America, 7University of Oxford, United Kingdom Canine" exact="diabetes mellitus" post="(DM) is more prevalent in certain breeds, suggesting an"/>
 <result pre="in canine DM and insulinoma. Previous genetics work in canine" exact="diabetes mellitus" post="(DM) has focused on candidate genes and genome‐wide association"/>
 <result pre="HiSeqX technology. Six Samoyeds and 6 Boxers without DM or" exact="insulinoma" post="underwent WGS as controls. DNA was extracted from blood"/>
 <result pre="Boxer, and 68 of which were found exclusively in the" exact="insulinoma" post="group. Replication and functional studies are in progress to"/>
 <result pre="the most sensitive and specific test for the diagnosis of" exact="pancreatitis" post="in dogs. However, relatively high costs and long turnaround"/>
 <result pre="activity in dogs affected by naturally occurring hypercortisolism. Dogs with" exact="acute pancreatitis" post="(AP) and healthy dogs (HD) were used as controls."/>
 <result pre="in dogs affected by naturally occurring hypercortisolism. Dogs with acute" exact="pancreatitis" post="(AP) and healthy dogs (HD) were used as controls."/>
 <result pre="popularity. However, there are concerns regarding its ability to differentiate" exact="hypothyroidism" post="from non‐thyroidal illness (NTI). The aim of this study"/>
 <result pre="serum samples from 150 dogs with various NTIs in which" exact="hypothyroidism" post="was not suspected. Total T4 concentration (Immulite Canine Total"/>
 <result pre="these results, fT4a cannot be recommended to differentiate NTI from" exact="hypothyroidism" post="in dogs with a low total T4 concentration. This"/>
 <result pre="of follicular‐cell thyroid carcinoma: a novel canine model for translational" exact="thyroid cancer" post="research E. Tièche* 1, K. Hahn* 2, M. Dettwiler"/>
 <result pre="follicular‐cell thyroid carcinoma: a novel canine model for translational thyroid" exact="cancer" post="research E. Tièche* 1, K. Hahn* 2, M. Dettwiler"/>
 <result pre="in 3‐dimensional cell culture systems (organoids) has revolutionized in vitro" exact="cancer" post="research. In contrast to 2‐D cell lines, organoids can"/>
 <result pre="human medicine, organoid cultures provide a unique platform for personalized" exact="cancer" post="therapy. In this study, we aimed to culture and"/>
 <result pre="model to better understand the pathogenesis and optimize treatment of" exact="thyroid cancer" post="in dogs. The culture protocol likely requires further optimization."/>
 <result pre="to better understand the pathogenesis and optimize treatment of thyroid" exact="cancer" post="in dogs. The culture protocol likely requires further optimization."/>
 <result pre="Tierklinik Hollabrunn, Hollabrunn, Austria In humans, airway narrowing due to" exact="asthma" post="or COPD commonly results in heterogeneous deposition of aerosols"/>
 <result pre="and WHWT dogs, a breed with high susceptibility for canine" exact="idiopathic pulmonary fibrosis" post="(CIPF). Bronchoalveolar lavage fluid (BALF) was obtained under anaesthesia"/>
 <result pre="WHWT dogs, a breed with high susceptibility for canine idiopathic" exact="pulmonary fibrosis" post="(CIPF). Bronchoalveolar lavage fluid (BALF) was obtained under anaesthesia"/>
 <result pre="dysphagia, regurgitation, or vomiting. In dogs, reflux likely contributes to" exact="respiratory disease" post="pathogenesis and progression. Our study objectives were as follows:"/>
 <result pre="Fellow Program. ESVIM‐O‐4 Serum 25‐hydroxyvitamin D in dogs with sinonasal" exact="aspergillosis" post="J. Jaffey 1, C. Clercx 2, F. Billen 2,"/>
 <result pre="of illness with a variety of inhaled respiratory pathogens. Sinonasal" exact="aspergillosis" post="(SNA) is a common cause of chronic nasal disease"/>
 <result pre="lack of association. Disclosures No disclosures to report. ESVIM‐O‐6 Hereditary" exact="methemoglobinemia" post="in dogs caused by cytochrome b5 reductase deficiency associated"/>
 <result pre="(Fe 3+), which is incapable of binding O 2. Hereditary" exact="methemoglobinemia" post="in dogs is most commonly caused by cytochrome b"/>
 <result pre="dog. Scattered case reports show varied clinical consequences of hereditary" exact="methemoglobinemia" post="in dogs. Therefore, the objectives of this study were"/>
 <result pre="radiographs of the thorax revealed abnormalities in 11/51 dogs. Sternal" exact="lymphadenopathy" post="and cardiomegaly were documented in 4 dogs respectively and"/>
 <result pre="in 13, diffuse steatitis in 11, enlarged pancreas and abdominal" exact="lymphadenopathy" post="in 8 and splenomegaly in 7 dogs. Hepatomegaly and"/>
 <result pre="in one third of collected bile samples. Hepatosplenomegaly and abdominal" exact="lymphadenopathy" post="were uncommonly associated with neoplasia. Disclosures No disclosures to"/>
 <result pre="undefined. Disclosures No disclosures to report. ESVIM‐O‐11 Treatment of non‐lactate" exact="metabolic acidosis" post="in hypovolemic and normovolemic dogs: chloride‐free iso‐osmolar solution with"/>
 <result pre="Torino, Italy The use of sodium bicarbonate‐based solutions for treating" exact="metabolic acidosis" post="is currently debated. The alkalizing effect of solutions with"/>
 <result pre="(Hyper‐SID), compared to Ringer's lactate used for the treatment of" exact="metabolic acidosis." post="Hyper‐SID solution was prepared by adding 145 mEq/L of sodium,"/>
 <result pre="superior to the RL solution in the treatment of non‐lactate" exact="metabolic acidosis" post="in hospitalized dogs. In the sample of subjects belonging"/>
 <result pre="These 8 sessions were performed in 6 dogs: 4 had" exact="leptospirosis" post="and 2 poisoning (grape and ethylene glycol), 4 died."/>
 <result pre="Clinic, Bordeaux, France, 2INTHERES, Toulouse University, Toulouse, France Cats with" exact="chronic kidney disease" post="(CKD) are often presented when a superimposed acute uremic"/>
 <result pre="University of Glasgow Veterinary Fund Small Grant Scheme. ESVNU‐O‐4 Immune‐complex" exact="glomerulonephritis" post="in cats: a retrospective study based on clinico‐pathological data"/>
 <result pre="has typically a non‐immune mediated origin in cats and immune‐complex" exact="glomerulonephritis" post="(ICGN) has been scarcely described. To date, few descriptions"/>
 <result pre="Additionally, comparisons were performed with cats affected by non immune‐complex" exact="glomerulonephritis" post="(non‐ICGN). Renal biopsies of cats with ICGN and non‐ICGN"/>
 <result pre="included breed, sex, age, feline immunodeficiency virus (FIV) and feline" exact="leukemia" post="virus (FeLV) status, serum creatinine concentration, urine protein‐to‐creatinine (UPC)"/>
 <result pre="cats affected by ICGN, 18 (48.6%) had MGN, 14 (37.8%)" exact="membranoproliferative glomerulonephritis" post="(MPGN) and 5 (13.5%) mesangioproliferative glomerulonephritis. Breed, sex, age,"/>
 <result pre="affected by ICGN, 18 (48.6%) had MGN, 14 (37.8%) membranoproliferative" exact="glomerulonephritis" post="(MPGN) and 5 (13.5%) mesangioproliferative glomerulonephritis. Breed, sex, age,"/>
 <result pre="to an E. coli probiotic as a potential therapeutic for" exact="urinary tract infection" post="C. Snell 1, J. Gibson 1, C. Zumpetta 1,"/>
 <result pre="using microcidin plate analysis. Clinical signs were consistent with lower" exact="urinary tract infection" post="in all cats. Serogroup and virulence factors correlated with"/>
 <result pre="interest. ESVNU‐O‐7 Prognostic factors in dogs with common causes of" exact="proteinuria" post="F. Baumgartner, F. Boretti, B. Gerber Vetsuisse Faculty, University"/>
 <result pre="aim of this study was to assess dogs with severe" exact="proteinuria" post="(UPC at least once during the disease measured &amp;gt;2.0)"/>
 <result pre="and haematocrit. Between 2014 and 2015, 89 dogs with severe" exact="proteinuria" post="were retrospectively analysed. Among them, 46 dogs were diagnosed"/>
 <result pre="are current employees of Royal Canin, Mars Petcare. ESVNU‐O‐9 Proliferative" exact="urethritis" post="in dogs: long‐term follow up and prognosis R. Caccamo"/>
 <result pre="of Bologna, Italy, 3Endovet ‐ Professional Association, Rome, Italy Proliferative" exact="urethritis" post="(PU) is an uncommon inflammatory disease with unknown etiology."/>
 <result pre="A retrospective multi‐centre study on treatment and outcome in disseminated" exact="aspergillosis" post="in 41 dogs J.R.S. Dandrieux 1, C.S. Mansfield 1,"/>
 <result pre="Werribee, Australia, 2Asia‐Pacific Centre for Animal Health, Melbourne, Australia Disseminated" exact="aspergillosis" post="(DA) in dogs has a guarded prognosis. The aim"/>
 <result pre="systemic or digestive signs, or to biological abnormalities such as" exact="anemia" post="or hypoalbuminemia, were excluded. Clinical signs, biological abnormalities and"/>
 <result pre="age of infected dogs was 4 years. Overall, clinical signs included" exact="diarrhea" post="(49%), weight loss (38%), hematochezia (29%), inappetence (24%), vomiting"/>
 <result pre="dogs and chronic in the remaining dogs. Biological abnormalities included" exact="anemia" post="(23%), eosinophilia (30%), hypoalbuminemia (60%) and Na/K ratio &amp;lt; 24 with"/>
 <result pre="chronic in the remaining dogs. Biological abnormalities included anemia (23%)," exact="eosinophilia" post="(30%), hypoalbuminemia (60%) and Na/K ratio &amp;lt; 24 with normal ACTH‐stimulation"/>
 <result pre="leading to both acute and chronic digestive clinical signs, hypoalbuminemia," exact="anemia" post="and electrolytes disorders. Disclosures No disclosures to report. ISCAID‐O‐8"/>
 <result pre="prescriptions for respiratory and urinary tract infections (UTI) and acute" exact="diarrhea" post="from two Swiss university hospitals and 14 private practices"/>
 <result pre="Antimicrobial therapy was significantly associated with the presence of bloody" exact="diarrhea" post="( P &amp;lt; 0.001). It complied in 43.5% (120/276; JS‐1)"/>
 <result pre="Gow, M. Salavati The University of Edinburgh, Roslin, Scotland Hepatic" exact="encephalopathy" post="(HE) is a syndrome of neurologic dysfunction and an"/>
 <result pre="when compared to weeks 5 and 9. Finally, an extrapolated" exact="cirrhosis" post="dysbiosis ratio (CDR) was calculated, for which lower values"/>
 <result pre="town, South Africa, 4University of Pretoria, Pretoria, South Africa Bacterial" exact="cholecystitis" post="is a debilitating disease in dogs. The presence of"/>
 <result pre="Maltese dogs with moderately increased postprandial bile acids and no" exact="liver disease" post="based on imaging (n = 3), dogs with histologically"/>
 <result pre="portal vein hypoplasia (n = 4) or histologically confirmed chronic" exact="hepatitis" post="(n = 3). All samples were analysed in batch"/>
 <result pre="is a valuable treatment option for dogs and cats with" exact="cancer" post="after failing first line therapy M. Kleiter 1, L."/>
 <result pre="cats receiving re‐irradiation because of progressive tumor recurrence. Small animal" exact="cancer" post="patients treated with re‐irradiation between 2006‐2017 were included into"/>
 <result pre="to target receptors that are uniquely or highly expressed by" exact="cancer" post="cells, improving tumor specificity with reduced adverse events (AEs)."/>
 <result pre="target tumor cells and associated vascular and inflammatory stroma for" exact="sarcoma" post="therapy. It consists of human EGF, targeting the EGF"/>
 <result pre="species and applications. ESVONC‐O‐4 Humoral hypercalcemia of malignancy in canine" exact="lymphoma" post="WHO types and its impact on survival O.P. Skor"/>
 <result pre="of malignancy (HHM) is a common paraneoplastic syndrome in canine" exact="lymphoma" post="and has always been considered a negative prognostic factor."/>
 <result pre="factor. However, studies analyzing the role of HHM in WHO" exact="lymphoma" post="types are lacking. The aim of this study was"/>
 <result pre="study was to evaluate the incidence of HHM among different" exact="lymphoma" post="types and its prognostic impact on survival. In a"/>
 <result pre="In a retrospective study data of dogs diagnosed with untreated" exact="lymphoma" post="between 2008 and 2019 were analyzed. Inclusion criteria were"/>
 <result pre="with T‐lymphomas were affected. 9/14 (64%) suffered from peripheral T‐cell" exact="lymphoma" post="(PTLC) and 5/14 (36%) from T‐lymphoblastic lymphoma (T‐LBL). HHM"/>
 <result pre="from peripheral T‐cell lymphoma (PTLC) and 5/14 (36%) from T‐lymphoblastic" exact="lymphoma" post="(T‐LBL). HHM occurred in 43% (9/21) of PTLC and"/>
 <result pre="in progression free survival (150 vs. 60 days, P = 0.29) or" exact="lymphoma" post="specific survival (170 vs. 135 days, P = 0.42) were observed"/>
 <result pre="unfavorable prognostic factor but it is associated with aggressive T‐cell" exact="lymphoma" post="types. Prospective studies assessing the role of vitamin D3,"/>
 <result pre="during and after DOX infusion. Dogs with cytologically/histopathologically confirmed high‐grade" exact="lymphoma" post="were screened with an echocardiogram and concurrent electrocardiogram for"/>
 <result pre="remains the best anatomic staging of human diffuse large B‐cell" exact="lymphoma" post="(DLBCL). AAS divides patients into four stages based on"/>
 <result pre="free survival (PFS) (116 vs. 332 days, P = 0.001) and" exact="lymphoma" post="specific survival (LSS) (180 vs. 489 days, P = 0.001)."/>
 <result pre="larger cohort of patients with standardized staging and in other" exact="lymphoma" post="types are warranted. Disclosures No disclosures to report. ESVONC‐O‐8"/>
 <result pre="significant difference between the survival outcomes according to carcinoma or" exact="sarcoma" post="diagnoses. Historically, canine nasal tumours treated surgically achieved a"/>
 <result pre="Medicine &amp;amp; B, College Station, United States of America Alimentary" exact="lymphoma" post="is one of the most common forms of neoplasia"/>
 <result pre="low‐dose radiation therapy for feline intermediate and small cell alimentary" exact="lymphoma" post="as an alternative to chronic chemotherapy or in patient's"/>
 <result pre="helical tomotherapy for treatment of intermediate and small cell alimentary" exact="lymphoma" post="in feline patients. Exclusion criteria, disease extension beyond intestines"/>
 <result pre="if available for the patient. Ten cats diagnosed with alimentary" exact="lymphoma" post="were treated with low‐dose radiation. Seven cats diagnosed with"/>
 <result pre="treated with low‐dose radiation. Seven cats diagnosed with small cell" exact="lymphoma" post="were treated with 3 Gy total and three diagnosed with"/>
 <result pre="treated with 3 Gy total and three diagnosed with intermediate cell" exact="lymphoma" post="were treated with 4 Gy total. Acute effects associated with"/>
 <result pre="of low‐dose radiation therapy for intermediate and small cell alimentary" exact="lymphoma" post="as a salvage or an alternative to oral chemotherapy"/>
 <result pre="and histopathological lesions in relation to outcomes in canine immunosuppressant‐responsive" exact="enteropathy" post="(Ire): prospective analysis in 57 dogs E. Benvenuti 1,"/>
 <result pre="Veterinary Medical Sciences, University of Bologna, Bologna, Italy Canine immunosuppressant‐responsive" exact="enteropathy" post="(IRE) is an intestinal idiopathic inflammation, in which diet"/>
 <result pre="also determined (semi‐quantitative and/or quantitative analyses) with results consistent with" exact="pancreatitis" post="in 50%(19/38). Among patients with normal cPLI results, pancreatitis"/>
 <result pre="with pancreatitis in 50%(19/38). Among patients with normal cPLI results," exact="pancreatitis" post="was suspected in 2 based on pancreatic histology (n"/>
 <result pre="= 1) and abdominal ultrasound (n = 1), and non‐cirrhotic" exact="portal hypertension" post="(n = 1) and gastrointestinal disease (n = 16)"/>
 <result pre="= 1), and non‐cirrhotic portal hypertension (n = 1) and" exact="gastrointestinal disease" post="(n = 16) were diagnosed in the other 17"/>
 <result pre="17 patients. Gastrointestinal disease was confirmed in 11 cases [food‐responsive" exact="enteropathy" post="(5), IBD (4), gastrointestinal neoplasia (2)] and pressumptive in"/>
 <result pre="without cPLI analyses. In 30 patients underlying disease was confirmed:" exact="gastrointestinal disease" post="(15), hepatopathy (4), renal disease (3), hypoadrenocorticism (1), insulinoma"/>
 <result pre="gastrointestinal disease (15), hepatopathy (4), renal disease (3), hypoadrenocorticism (1)," exact="insulinoma" post="(1), neoplasia (2) and poliartritis (1). In the 11"/>
 <result pre="with presumptive diagnosis, the most likely underlying disease was chronic" exact="enteropathy" post="(n = 9). In the present study 76,9% (40/52)"/>
 <result pre="study 76,9% (40/52) of cases with increased TLI and without" exact="pancreatitis" post="or azotemia had confirmed or suspected underlying gastrointestinal disease,"/>
 <result pre="and without pancreatitis or azotemia had confirmed or suspected underlying" exact="gastrointestinal disease," post="coincident with previous feline and human findings. In fact"/>
 <result pre="fact TLI was performed in those cases to rule out" exact="exocrine pancreatic insufficiency." post="Although cobalamin deficiency has been linked to increased feline"/>
 <result pre="and TLI levels must be carefully interpreted in animals with" exact="gastrointestinal disease." post="Disclosures No disclosures to report. ESCG‐P‐3 Serum 25‐hydroxyvitamin D3"/>
 <result pre="Denmark Hypovitaminosis D has been linked to systemic inflammation, chronic" exact="enteropathy" post="(CE) and cancer in dogs. It is unknown if"/>
 <result pre="has been linked to systemic inflammation, chronic enteropathy (CE) and" exact="cancer" post="in dogs. It is unknown if changes in serum"/>
 <result pre="D 3 [25(OH)D 3] are seen in dogs with acute" exact="enteropathy" post="(AE). This study aimed to investigate [25(OH)D 3] in"/>
 <result pre="cPL, the severity of disease and mortality in suspected canine" exact="acute pancreatitis" post="E. Gori, A. Pierini, I. Lippi, S. Citi, T."/>
 <result pre="the severity of disease and mortality in suspected canine acute" exact="pancreatitis" post="E. Gori, A. Pierini, I. Lippi, S. Citi, T."/>
 <result pre="Mannucci, V. Marchetti University of Pisa, Pisa, Italy In canine" exact="acute pancreatitis" post="(AP) abdominal ultrasound (US) is a widely‐used non‐invasive diagnostic"/>
 <result pre="V. Marchetti University of Pisa, Pisa, Italy In canine acute" exact="pancreatitis" post="(AP) abdominal ultrasound (US) is a widely‐used non‐invasive diagnostic"/>
 <result pre="recruitment, anamnesis and laboratory minimal database were performed. Canine chronic" exact="enteropathy" post="clinical activity index (CCECAI) and signs of gastroesophageal reflux"/>
 <result pre="also revise the diagnostic criteria for atrophy. Keywords: gastric, carcinoma," exact="atrophic gastritis," post="metaplasia, dysplasia, dog. Disclosures Disclosures to report. Statement of"/>
 <result pre="deficiency is a common finding in dogs diagnosed with chronic" exact="enteropathy" post="(CE) due to low absorption and/or bacterial competition. It"/>
 <result pre="based on the response to treatment (ie, diagnosis of food‐responsive" exact="enteropathy" post="[FRE] vs. steroid−/immunosuppressant‐responsive enteropathy [IRE]). The neutrophil‐to‐lymphocyte ratio (NLR)"/>
 <result pre="to treatment (ie, diagnosis of food‐responsive enteropathy [FRE] vs. steroid−/immunosuppressant‐responsive" exact="enteropathy" post="[IRE]). The neutrophil‐to‐lymphocyte ratio (NLR) was recently shown to"/>
 <result pre="significantly higher in dogs with histologic lesions compatible with protein‐losing" exact="enteropathy" post="( P = 0.006). Hypoalbuminemia ( P &amp;lt; 0.001), but not"/>
 <result pre="in feces and serum samples from dogs with chronic inflammatory" exact="enteropathy" post="(CIE). However, intestinal mucosal calprotectin concentrations have not been"/>
 <result pre="report. ESCG‐P‐9 Neutrophil‐to‐lymphocyte ratio (NLR) in canine patients with immunosuppressant‐responsive" exact="enteropathy" post="(IRE) E. Benvenuti 1, E. Gori 1, A. Pierini"/>
 <result pre="the study was to evaluate the NLR in canine immunosuppressant‐responsive" exact="enteropathy" post="(IRE). Forty‐one dogs presented to two veterinary facilities (Veterinary"/>
 <result pre="report. ESCG‐P‐13 The erythrocyte membrane lipidome in dogs with chronic" exact="enteropathy" post="P.E. Crisi 1, P. Prasinou 1, C. ferreri 2,"/>
 <result pre="cause for persistent or recurrent gastrointestinal signs in dogs. Food‐responsive" exact="enteropathy" post="(FRE), antimicrobial‐responsive enteropathy (ARE), and immunosuppressive‐responsive enteropathy (IRE) have"/>
 <result pre="or recurrent gastrointestinal signs in dogs. Food‐responsive enteropathy (FRE), antimicrobial‐responsive" exact="enteropathy" post="(ARE), and immunosuppressive‐responsive enteropathy (IRE) have different etiologies however"/>
 <result pre="in dogs. Food‐responsive enteropathy (FRE), antimicrobial‐responsive enteropathy (ARE), and immunosuppressive‐responsive" exact="enteropathy" post="(IRE) have different etiologies however clinical signs overlap and"/>
 <result pre="could be associated with specific conditions such as neoplasia and" exact="liver disease" post="and, in addition, may be a marker of severity."/>
 <result pre="Inflammatory bowel disease (IBD) is a common cause of chronic" exact="gastrointestinal disease" post="in dogs. The current paradigm of IBD involves complex"/>
 <result pre="ESCG‐P‐17 Serum Vitamin A and E concentrations in dogs with" exact="pancreatitis" post="M. Weiβ, K. Törner, H. Aupperle‐Lellbach, E. Müller Laboklin"/>
 <result pre="GmbH und Co KG, Bad Kissingen, Germany Acute and chronic" exact="pancreatitis" post="in humans results in significantly lower levels of serum"/>
 <result pre="Vitamin A and E levels in serum of dogs with" exact="pancreatitis" post="have been performed so far. The aim of this"/>
 <result pre="and E from routine diagnostic left‐over samples in dogs with" exact="pancreatitis" post="compared to a control group of dogs with other"/>
 <result pre="control group of dogs with other diseases. 40 dogs with" exact="pancreatitis" post="were included in this study. These dogs all had"/>
 <result pre="had serum pancreatic lipase concentrations &amp;gt;600 μg/L and clinical symptoms of" exact="pancreatitis" post="like vomiting, abdominal pain or inappetence and had received"/>
 <result pre="received no medical treatment so far. Additionally, in 3 dogs" exact="pancreatitis" post="was diagnosed by histology of pancreatic tissue biopsies. The"/>
 <result pre="HPLC from cooled serum within 72 hours of sampling. Dogs with" exact="pancreatitis" post="had significantly higher ( P &amp;lt; 0.001) levels of serum"/>
 <result pre="(average: 20.4 μg/L, range: 1,9‐54.6 μg/L). This study suggests that dogs with" exact="pancreatitis" post="have a different metabolism of Vitamin A and E"/>
 <result pre="other diseases and humans with pancreatitis. In the course of" exact="pancreatitis" post="a release of Vitamin A and E into the"/>
 <result pre="and significantly increases the visualization of mucosal texture and the" exact="adenoma" post="detection rate. This study was the first in veterinary"/>
 <result pre="Heart rate variability of dogs in various stages of degenerative" exact="mitral valve disease" post="R.A. Baisan 1, V. Vulpe 1, D.G. Ohad 2"/>
 <result pre="rate assessed by 2‐dimensional speckle tracking echocardiography in dogs with" exact="pulmonary hypertension" post="D. Caivano 1, M. Rishniw 2, F. Birettoni 1,"/>
 <result pre="2‐dimensional speckle tracking echocardiography in healthy dogs and dogs with" exact="pulmonary hypertension," post="to identify dogs with pulmonary hypertension. Additionally, we examined"/>
 <result pre="dogs and dogs with pulmonary hypertension, to identify dogs with" exact="pulmonary hypertension." post="Additionally, we examined relationships of transverse strain and strain"/>
 <result pre="regurgitation (TR) velocity and left atrial size in dogs with" exact="pulmonary hypertension." post="We acquired 2D echocardiographic cineloops from the left apical"/>
 <result pre="pulmonary hypertension) using Xstrain® software. Dogs were classified as having" exact="pulmonary hypertension" post="based on the TR jet velocity (&amp;gt; 3 m/sec). We classified"/>
 <result pre="TR jet velocity (&amp;gt; 3 m/sec). We classified dogs as having moderate" exact="pulmonary hypertension" post="if TR velocity &amp;gt; 3.5 m/sec, and severe pulmonary hypertension if TR"/>
 <result pre="as having moderate pulmonary hypertension if TR velocity &amp;gt; 3.5 m/sec, and severe" exact="pulmonary hypertension" post="if TR velocity &amp;gt; 4.5 m/sec. Seven dogs (3 healthy and 4"/>
 <result pre="with heart rate, body weight or age. In dogs with" exact="pulmonary hypertension," post="strain and strain rate showed weak negative relationships with"/>
 <result pre="not strain rate) showed a negative relationship with class of" exact="pulmonary hypertension," post="it was not useful in identifying dogs with pulmonary"/>
 <result pre="pulmonary hypertension, it was not useful in identifying dogs with" exact="pulmonary hypertension." post="Transverse RV strain and strain rate using 2‐dimensional speckle"/>
 <result pre="most dogs, but does not help in identifying dogs with" exact="pulmonary hypertension." post="Disclosures No disclosures to report. ESVC‐P‐4 Potential renoprotective effect"/>
 <result pre="Potential renoprotective effect of angiotensin‐receptor antagonists in dogs with myxomatous" exact="mitral valve disease" post="J. Lee 1, W. Kim 2, H. Hwang 1,"/>
 <result pre="Blockade of renin‐angiotensin‐aldosterone system is a pivotal strategy to manage" exact="congestive heart failure" post="(CHF). Angiotensin‐receptor blockers (ARBs) are perceived to offer more"/>
 <result pre="Angiotensin‐receptor blockers (ARBs) are perceived to offer more complete neurohormonal" exact="suppression" post="in the treatment of CHF by directly occupying angiotensin"/>
 <result pre="has clinically incremental benefits, is unknown in dogs with myxomatous" exact="mitral valve disease" post="(MMVD). This retrospective cohort study was conducted with client‐owned"/>
 <result pre="concentration, renal function and survival in 85 dogs with acute" exact="congestive heart failure" post="E. Martinelli 1, A. Galizzi 1, R. Toschi Corneliani"/>
 <result pre="University of Milan, Milano, Italy Critically hill patients with acute" exact="congestive heart failure" post="(CHF) may often show haemoconcentration, dysnatremia, dyskalemia and increased"/>
 <result pre="showing extra‐range values (T0‐T1) were respectively: hyponatremia (10‐23), hypernatremia (13‐17)," exact="hypokalemia" post="(18‐30), hyperkalemia (10‐10), hypocloremia (46‐61), increased BUN (26‐34), increased"/>
 <result pre="its metabolite, 3‐epi‐25(OH)D 3 (3‐epi), are lower in cats with" exact="cardiomyopathy" post="(CM) vs. normal cats, or if associations with certain"/>
 <result pre="Iowa State (ISU) and Tufts Universities; 38 CM cats had" exact="congestive heart failure." post="Exclusion criteria included hypertension, hyperthyroidism, and clinically relevant systemic"/>
 <result pre="desmin aggregates consistent with intermediate filament dysfunction in feline hypertrophic" exact="cardiomyopathy" post="W.C. Cheng 1, M. Dobromylskyj 2, L.J. Wilkie 1,"/>
 <result pre="folding are reported in humans and rodent models with hypertrophic" exact="cardiomyopathy" post="(HCM). Incorrect folding of desmin leads to its aberrant"/>
 <result pre="No disclosures to report. ESVC‐P‐10 Prevalence and risk factors for" exact="atrial fibrillation" post="in dogs with myxomatous mitral valve disease C. Guglielmini"/>
 <result pre="and risk factors for atrial fibrillation in dogs with myxomatous" exact="mitral valve disease" post="C. Guglielmini 1, M.G. Sousa 2, M. Baron Toaldo"/>
 <result pre="and risk factors for this arrhythmia in dogs with myxomatous" exact="mitral valve disease" post="(MMVD). The aims of this study were to estimate"/>
 <result pre="in 160 Cavalier King Charles Spaniels with and without degenerative" exact="mitral valve disease" post="(2017‐2019) C. Poissonnier 1, P. Foulex 2, M.P. Alvarado"/>
 <result pre="d'Alfort, Maisons‐Alfort, France, 2Ecole Nationale Vétérinaire d'Alfort, Maisons‐Alfort, France Degenerative" exact="mitral valve disease" post="(DMVD) is the most common acquired heart disease in"/>
 <result pre="Degenerative mitral valve disease (DMVD) is the most common acquired" exact="heart disease" post="in small‐sized dogs with a high predisposition of the"/>
 <result pre="B1 and B2, respectively, 23/160 (14.3%) had past or current" exact="congestive heart failure" post="(CHF, stage C), and 1/160 (0.6%) had refractory CHF"/>
 <result pre="dogs (median proportion = 45‰ cells [IQR = 10‐226‰]), and" exact="hemolytic anemia" post="in 4 dogs with PS (hemoglobinemia &amp;lt;12.4 g/dL). No significant"/>
 <result pre="(median proportion = 45‰ cells [IQR = 10‐226‰]), and hemolytic" exact="anemia" post="in 4 dogs with PS (hemoglobinemia &amp;lt;12.4 g/dL). No significant"/>
 <result pre="above‐mentioned echocardiographic parameters. Three out of the 4 dogs with" exact="hemolytic anemia" post="had a maximal ∆ P &amp;gt; 200 mmHg (242 to 412 mmHg)."/>
 <result pre="echocardiographic parameters. Three out of the 4 dogs with hemolytic" exact="anemia" post="had a maximal ∆ P &amp;gt; 200 mmHg (242 to 412 mmHg)."/>
 <result pre="with the highest maximal ∆P also had the most severe" exact="anemia" post="and schizocytosis, and both abnormalities decreased, and then resolved,"/>
 <result pre="whose safety and efficacy have been demonstrated in dogs with" exact="congestive heart failure" post="(CHF). Torasemide is characterized by a longer duration of"/>
 <result pre="All cats presented dyspnea related to CHF (pleural effusion [4/17]," exact="pulmonary edema" post="[6/17]or both [7/17]), associated with ascites in 2/17 cats."/>
 <result pre="of torasemide as a second line diuretic in dogs with" exact="congestive heart failure" post="I. Guarnera, G. Romito, P. Castagna, M. Cipone, M."/>
 <result pre="Italy Torasemide is a loop diuretic used in dogs with" exact="congestive heart failure" post="(CHF) as an alternative to furosemide. Studies comparing furosemide"/>
 <result pre="Teaching Hospital has been reviewed searching for dogs with myxomatous" exact="mitral valve disease" post="who experienced CHF and received torasemide as a second"/>
 <result pre="= 0.230) serum levels. There was no difference in prevalence of" exact="atrial fibrillation" post="between groups ( P = 1.000). The overall number of"/>
 <result pre="second line diuretic for CHF control in dogs with myxomatous" exact="mitral valve disease," post="offering a life expectance comparable if not superior to"/>
 <result pre="disclosures to report. ESVC‐P‐15 Echocardiographic predictors of first onset of" exact="atrial fibrillation" post="in dogs with myxomatous mitral valve disease C. Mazzoldi"/>
 <result pre="of first onset of atrial fibrillation in dogs with myxomatous" exact="mitral valve disease" post="C. Mazzoldi 1, C. Guglielmini 2, G. Romito 1,"/>
 <result pre="Padova, Italy Atrial fibrillation (AF) occurs in dogs with myxomatous" exact="mitral valve disease" post="(MMVD) as a consequence of left atrial (LA) dilatation."/>
 <result pre="frequent (&amp;gt;100) premature ectopic complexes (SR + PEC), either supraventricular or ventricular;" exact="atrial fibrillation" post="(AF); and AF with frequent ventricular premature complexes (AF + VPC)."/>
 <result pre="complex supraventricular ectopy, ventricular premature complexes (VPCs), complex ventricular ectopy," exact="atrial fibrillation" post="(AF), high‐grade second degree atrioventricular block (AVB) and paced"/>
 <result pre="(VPCs), complex ventricular ectopy, atrial fibrillation (AF), high‐grade second degree" exact="atrioventricular block" post="(AVB) and paced rhythms were retrospectively evaluated and utilized"/>
 <result pre="based 95% confidence interval may help in screening dogs for" exact="heart disease," post="discriminating normal aortic annulus dimension. Disclosures No disclosures to"/>
 <result pre="Ljubljana, Slovenia Various factors can influence survival of dogs with" exact="mitral valve disease" post="(MVD) and dilated cardiomyopathy (DCM). In canine cardiovascular patients,"/>
 <result pre="survival of dogs with mitral valve disease (MVD) and dilated" exact="cardiomyopathy" post="(DCM). In canine cardiovascular patients, inflammatory and antioxidant markers"/>
 <result pre="important index in the diagnosis of occult and symptomatic dilated" exact="cardiomyopathy" post="(DCM) as recently reported in the European screening guidelines"/>
 <result pre="effect of long flightprolonged air travel on dogs with heart" exact="mitral valve disease" post="A. Takahashi, S. Takeuchi, M. Uechi JASMINE veterinary cardiovascular"/>
 <result pre="Japan The effect of long air travel on animals with" exact="heart disease" post="has not been investigated. In this study, we assessed"/>
 <result pre="we assessed the changes in physical condition of animals with" exact="mitral valve disease" post="before and after flight. Target case profile: 38 dogs"/>
 <result pre="before and after flight. Target case profile: 38 dogs with" exact="mitral valve disease" post="who underwent air travel to undergo mitral valve repair"/>
 <result pre="were evaluated. Also presence or absence of events related to" exact="heart disease" post="post‐flying and post‐operative discharge rate were studied. All cases"/>
 <result pre="(2 dogs without surgery). Two dogs developed events related to" exact="mitral valve disease" post="(1 left atrium rupture and 1 pulmonary edema, respectively)."/>
 <result pre="to mitral valve disease (1 left atrium rupture and 1" exact="pulmonary edema," post="respectively). The dog with left atrial rupture died before"/>
 <result pre="receive cardiac medications during the flight. The dog that developed" exact="pulmonary edema" post="post‐flight also missed a dose during the journey, but"/>
 <result pre="showed gastrointestinal symptoms (vomiting, diarrhea) before flight. Three patients developed" exact="diarrhea" post="after the flight. Among patients who showed respiratory symptoms"/>
 <result pre="the flight. One dog had post‐flight syncope.. Although dogs with" exact="mitral valve disease" post="may show clinical changes related to air travel, these"/>
 <result pre="clock due to time difference may be sufficient to avert" exact="mitral valve disease" post="related events with sufficient alertness. In conclusion, long distance"/>
 <result pre="alertness. In conclusion, long distance air travel of patients with" exact="mitral valve disease" post="can be safely performed by carrying out routine care"/>
 <result pre="infarction (AMI) is the most common cause of human ischemic" exact="heart disease." post="Its pathogenesis involves atherosclerosis of coronary arteries, platelet activation,"/>
 <result pre="common cause of human ischemic heart disease. Its pathogenesis involves" exact="atherosclerosis" post="of coronary arteries, platelet activation, thrombosis and vasospasms. Only"/>
 <result pre="Only anecdotal information on canine AMI exists. Postmortem descriptions of" exact="arteriosclerosis" post="with myocardial ischemic injury and congestive heart failure are"/>
 <result pre="exists. Postmortem descriptions of arteriosclerosis with myocardial ischemic injury and" exact="congestive heart failure" post="are available, but clinical data regarding ante‐mortem diagnosis of"/>
 <result pre="identified in 9 dogs (4 postoperative, 3 neoplastic, 1 immune‐mediated" exact="hemolytic anemia" post="and 1 hypothyroidism). Common clinical findings were arrhythmia (13/13),"/>
 <result pre="in 9 dogs (4 postoperative, 3 neoplastic, 1 immune‐mediated hemolytic" exact="anemia" post="and 1 hypothyroidism). Common clinical findings were arrhythmia (13/13),"/>
 <result pre="(10/10). Identified ECG abnormalities were ventricular arrhythmias (9/13), 3rd degree" exact="atrioventricular block" post="(4/13) or sinus rhythm with right axis deviation (1/13)."/>
 <result pre="diseases in hypothyroid dogs. Records of 63 dogs diagnosed with" exact="hypothyroidism" post="have been examined for the presence or absence of"/>
 <result pre="presented non‐specific clinical signs such as vomiting, anorexia and lethargy," exact="diarrhea" post="and/or fever. Thirty four dogs (53.9%) were diagnosed with"/>
 <result pre="(Consultancy) Dechra Veterinary Products (Consultancy). ESVE‐P‐7 Survival in cats with" exact="diabetes mellitus" post="and chronic pancreatitis: a preliminary study of 36 cases"/>
 <result pre="Veterinary School of Alfort, Maisons‐Alfort, France Previous studies suggest that" exact="pancreatitis" post="could be a significant comorbidity in diabetic cats, even"/>
 <result pre="absence of digestive signs. Long‐term studies of diabetic cats with" exact="pancreatitis" post="are lacking and potential survival factors in such population"/>
 <result pre="epidemiological, biological and ultrasonographic findings in cats with concurrent chronic" exact="pancreatitis" post="(CP) and diabetes mellitus (DM) and 2/to document chronology"/>
 <result pre="ultrasonographic findings in cats with concurrent chronic pancreatitis (CP) and" exact="diabetes mellitus" post="(DM) and 2/to document chronology of both diseases, survival"/>
 <result pre="episode of ketoacidosis, history of hospitalization and US features suggesting" exact="biliary tract disease" post="were evaluated. Association of each criteria and ST was"/>
 <result pre="elevation of liver enzymes (63%), hyperproteinemia (61%), hyperbilirubinemia (47%) and" exact="hypokalemia" post="(54%). Median survival time (MST) was 955 days. Mortality rate"/>
 <result pre="of cats having at least one US finding compatible with" exact="biliary tract disease" post="was significantly higher and MST was also 2,57 times"/>
 <result pre="and having at least one ultrasonographic finding compatible with a" exact="biliary tract disease" post="is shorter than cats without any biliary lesion on"/>
 <result pre="once daily Protamine Zinc Recombinant Human Insulin (ProZinc®) in canine" exact="diabetes mellitus" post="S.J.M. Niessen 1, C. Kroh 2, S. Maruyama 2,"/>
 <result pre="research among diabetic dog owners emphasizes the negative impact of" exact="diabetes mellitus" post="(DM) treatment on owner lifestyle, even leading to euthanasia."/>
 <result pre="437 ± 140 to 218 ± 84 mg/dL, and fructosamine from 566 ± 119 to 394 ± 83 μmol/L. Clinical" exact="hypoglycemia" post="was observed once in two SID treated dogs, which"/>
 <result pre="Disclosures No disclosures to report. ESVE‐P‐11 Prednisolone induced hyperglycaemia and" exact="diabetes mellitus" post="in cats S. Nerhagen, H. Moberg, B. Glanemann The"/>
 <result pre="in cats. Potential adverse effects include glucocorticoid‐induced hyperglycaemia (GIH) and" exact="diabetes mellitus" post="(GIDM) but predisposing factors for the development and the"/>
 <result pre="8 requiring insulin therapy and 1 was euthanized due to" exact="diabetic ketoacidosis." post="The remaining 5 cats (3.4%) were identified as GIH"/>
 <result pre="in the diagnosis of acid‐base basalnce disturbances in cats with" exact="chronic kidney disease" post="(CKD) P. Slawuta, A. Sikorska‐Kopylowicz, A. Kurosad, G. Sapikowski"/>
 <result pre="Environmental and Life Sciences, Wroclaw, Poland In addition to hypophosphatemia," exact="metabolic acidosis" post="is the most common complication of chronic kidney disease"/>
 <result pre="to hypophosphatemia, metabolic acidosis is the most common complication of" exact="chronic kidney disease" post="in cats. Using the standard approach, metabolic acidosis is"/>
 <result pre="of chronic kidney disease in cats. Using the standard approach," exact="metabolic acidosis" post="is diagnosed based on the concentration of HCO 3"/>
 <result pre="the chloride/sodium ratio (Cl −/Na +) in the diagnosis of" exact="metabolic acidosis." post="The study was carried out on 100 cats (both"/>
 <result pre="The analysis of the arterial blood revealed the presence of" exact="metabolic acidosis" post="in cats from group IV. In the remaining groups,"/>
 <result pre="is known about the role of exosomal miRNA in canine" exact="leishmaniasis" post="(CL); in particular, the interaction between exosomal miR‐122 and"/>
 <result pre="aim of this study was to investigate which type of" exact="anemia" post="and how are the serum iron levels in cats"/>
 <result pre="investigated by Mann‐Whitney test for iron, and Unpaired t‐test for" exact="anemia" post="parameters. Categorical data were analyzed with Fisher's exact test."/>
 <result pre="were analyzed with Fisher's exact test. Twenty‐nine cats (46%) showed" exact="anemia" post="which was more frequently mild (Hct &amp;lt; 26%; 62.1%) or moderate"/>
 <result pre="an infrequent finding (6.3%), and only two cats had microcytosis," exact="anemia" post="and hypoferremia concurrently. Hypoferremia (serum iron &amp;lt;90 mcg/dL) was"/>
 <result pre="iron &amp;lt;90 mcg/dL) was present in 34 cats and concurrent" exact="anemia" post="was observed in 15 cats (without any association between"/>
 <result pre="(without any association between these two parameters). Both hypoferremia and" exact="anemia" post="were more severe in group A (median serum iron"/>
 <result pre="B (median serum iron 90.5 mcg/dL; mean RBC 7.00 M/μL). Moreover," exact="anemia" post="was more frequently present in group A (63%; P"/>
 <result pre="P = 0.0048). The most plausible hypothesis for the origin of" exact="anemia" post="was the presence of a chronic disease. Decreased serum"/>
 <result pre="to detect comet‐tail artifacts (B lines) in animals with trauma," exact="pulmonary edema" post="or alveolar‐interstitial syndrome. The scanning protocols used in previous"/>
 <result pre="(16 with cardiac disease, 12 with cardiorespiratory comorbidities, 5 with" exact="respiratory disease," post="and 1 with non‐cardiorespiratory problem) were recruited in this"/>
 <result pre="stress. Disclosures No disclosures to report. ESVIM‐P‐12 Association between immune‐mediated" exact="hemolytic anemia" post="(IMHA) and acute pancreatitis in dogs G. Gianesini 1,"/>
 <result pre="Disclosures No disclosures to report. ESVIM‐P‐12 Association between immune‐mediated hemolytic" exact="anemia" post="(IMHA) and acute pancreatitis in dogs G. Gianesini 1,"/>
 <result pre="to report. ESVIM‐P‐12 Association between immune‐mediated hemolytic anemia (IMHA) and" exact="acute pancreatitis" post="in dogs G. Gianesini 1, M. Drigo 2, A."/>
 <result pre="report. ESVIM‐P‐12 Association between immune‐mediated hemolytic anemia (IMHA) and acute" exact="pancreatitis" post="in dogs G. Gianesini 1, M. Drigo 2, A."/>
 <result pre="Padova, Italy Evidences in humans, rats and cats suggest that" exact="acute pancreatitis" post="is a complication of hemolysis, including hemolysis from IMHA."/>
 <result pre="Italy Evidences in humans, rats and cats suggest that acute" exact="pancreatitis" post="is a complication of hemolysis, including hemolysis from IMHA."/>
 <result pre="from IMHA. This study investigates the association between IMHA and" exact="pancreatitis" post="in dogs. Case control study with nested retrospective cohort"/>
 <result pre="38.6%&quot; — 54.5%) and positive anti‐erythrocyte membrane antibodies test. Acute" exact="pancreatitis" post="was diagnosed if dogs had: amylase and lipase concentrations"/>
 <result pre="(RI, 0.01 — 0.22), and anorexia and/or vomiting. Frequency of" exact="pancreatitis" post="was compared among the 3 groups (fisher exact test)."/>
 <result pre="exact test). After admission dogs with IMHA with and without" exact="pancreatitis" post="had a 7‐day follow‐up. If some of the dogs"/>
 <result pre="7‐day follow‐up. If some of the dogs with IMHA without" exact="pancreatitis" post="developed pancreatitis, they switched to the IMHA with pancreatitis"/>
 <result pre="without pancreatitis developed pancreatitis, they switched to the IMHA with" exact="pancreatitis" post="group and were followed‐up for 7 days after the pancreatitis"/>
 <result pre="with pancreatitis group and were followed‐up for 7 days after the" exact="pancreatitis" post="event. Free plasma hemoglobin (Hb fp) for dogs with"/>
 <result pre="Free plasma hemoglobin (Hb fp) for dogs with IMHA with" exact="pancreatitis" post="(at the time of pancreatitis diagnosis) and without pancreatitis"/>
 <result pre="for dogs with IMHA with pancreatitis (at the time of" exact="pancreatitis" post="diagnosis) and without pancreatitis (at presentation) was calculated (Hb"/>
 <result pre="with pancreatitis (at the time of pancreatitis diagnosis) and without" exact="pancreatitis" post="(at presentation) was calculated (Hb fp = Hb tot ‐[RBC"/>
 <result pre="dogs with and without pancreatitis. Relative Risk (RR) of developing" exact="pancreatitis" post="in dogs with IMHA and Hb fp concentration ≥ the Youden"/>
 <result pre="calculated. Finally, 7‐day mortality between IMHA dogs with and without" exact="pancreatitis" post="was evaluated (chi square test). At presentation, frequency of"/>
 <result pre="pancreatitis was evaluated (chi square test). At presentation, frequency of" exact="pancreatitis" post="was significantly ( P = 0.0013) higher in dogs with"/>
 <result pre="further 9 dogs with IMHA developed pancreatitis. IMHA dogs with" exact="pancreatitis" post="(n = 21) had a significantly ( P = 0.0067)"/>
 <result pre="range, 0.0 — 1.55) compared to the IMHA dogs without" exact="pancreatitis" post="(n = 74; median = 0.0 g/dL, range, 0.0 —"/>
 <result pre="a Hb pf concentration ≥ 0.08 g/dL resulted in an increased risk of" exact="pancreatitis" post="(RR = 2.54, 95%CI, 1.51 — 4.29). There was"/>
 <result pre="IMHA are at increased risk of pancreatitis. Several dogs developed" exact="pancreatitis" post="after being diagnosis with IMHA, this may suggest that"/>
 <result pre="diagnosis with IMHA, this may suggest that IMHA may cause" exact="pancreatitis" post="and that Hb fp is a trigger for it."/>
 <result pre="Naples Fede, Naples, Italy In these last years, the increasing" exact="obesity" post="incidence in canine species has enshrined its relevance as"/>
 <result pre="has enshrined its relevance as an important worldwide disease. Recently," exact="obesity" post="has been associated with impaired immunity and chronic low‐grade"/>
 <result pre="obese dogs. Moreover, some evidences addressed the possible impact of" exact="obesity" post="on cardiovascular apparatus in dogs. The aim of this"/>
 <result pre="been recently shown to be particularly useful in discriminating bacterial" exact="bronchopneumonia" post="from other pulmonary diseases and promising in guiding antibiotic"/>
 <result pre="elevation was also compared with dogs diagnosed with bacterial aspiration" exact="bronchopneumonia" post="(ABP). Sixteen dogs with lower airways Bb infection and"/>
 <result pre="secondary physiologically appropriate polycythemia. However, the prevalence and severity of" exact="polycythemia" post="has not been described in detail in dogs with"/>
 <result pre="group comprised of 23 West Highland white terriers with canine" exact="idiopathic pulmonary fibrosis" post="and 21 dogs of other breeds with the following"/>
 <result pre="comprised of 23 West Highland white terriers with canine idiopathic" exact="pulmonary fibrosis" post="and 21 dogs of other breeds with the following"/>
 <result pre="following lung diseases; chronic bronchitis 13/21, eosinophilic bronchopneumopathy 2/21 and" exact="interstitial lung disease" post="2/21. In 4/21 dogs with chronic respiratory signs (cough"/>
 <result pre="lung diseases; chronic bronchitis 13/21, eosinophilic bronchopneumopathy 2/21 and interstitial" exact="lung disease" post="2/21. In 4/21 dogs with chronic respiratory signs (cough"/>
 <result pre="(mean 51.0 ± STD 5.7%, range 35‐64%, laboratory reference range 38‐57%). Marked" exact="polycythemia" post="(hematocrit ≥65%) was not noted in any of the"/>
 <result pre="Hkr r = −0.99, P = 0.521). These results indicate that" exact="polycythemia" post="is uncommonly encountered in dogs with chronic hypoxic pulmonary"/>
 <result pre="ESVIM‐P‐19 A statistical analysis to predict persistence of canine sinonasal" exact="aspergillosis" post="at endoscopic follow‐up by comparing three different scoring systems:"/>
 <result pre="of Liege, Liege, Belgium Dolichocephalic breeds are predisposed to sinonasal" exact="aspergillosis" post="while brachycephalic dogs are not affected. Since disruptions in"/>
 <result pre="sinonasal aspergillosis. Disclosures No disclosures to report. ESVIM‐P‐23 Canine sino‐nasal" exact="aspergillosis" post="in Italy (38 cases) A. Peano 1, G. Fortini"/>
 <result pre="di Scienze Veterinarie, Grugliasco, Italy, 2Endovet Freelance Group, Italy Sino‐nasal" exact="aspergillosis" post="(SNA) is an important cause of chronic nasal disease"/>
 <result pre="Ratio (UPC ratio) is currently the most frequent method for" exact="proteinuria" post="quantification. Proteinuria can be classified in physiological versus pathological"/>
 <result pre="classified in physiological versus pathological (pre‐renal, renal or post‐renal). Although" exact="chronic kidney disease" post="(CKD) is assumed to be the most common cause"/>
 <result pre="(CKD) is assumed to be the most common cause of" exact="proteinuria" post="in cats, few studies have been conducted to assess"/>
 <result pre="of this study was to determine the main causes of" exact="proteinuria" post="in cats from the region of Lisbon, Portugal. All"/>
 <result pre="and 2018 in a veterinary hospital and identified with significant" exact="proteinuria" post="(UPC ratio &amp;gt; 0.4) were included. The cause of proteinuria, International"/>
 <result pre="proteinuria, 46/61 (75%) presented renal proteinuria, 4/61 (7%) had post‐renal" exact="proteinuria" post="and 11/61 (18%) had a suspected mixed origin (renal"/>
 <result pre="origin (renal + post‐renal). In detail, the causes of renal" exact="proteinuria" post="were CKD (39/61; 64%), CKD complicated with co‐morbidities (2/61;"/>
 <result pre="and diseases capable of decreasing renal permselectivity (3/61; 5%). Post‐renal" exact="proteinuria" post="was due to urinary tract infection (UTI) (3/61; 5%)"/>
 <result pre="decreasing renal permselectivity (3/61; 5%). Post‐renal proteinuria was due to" exact="urinary tract infection" post="(UTI) (3/61; 5%) and cystitis (1/61; 2%). Mixed‐proteinuria was"/>
 <result pre="was due to urinary tract infection (UTI) (3/61; 5%) and" exact="cystitis" post="(1/61; 2%). Mixed‐proteinuria was attributed to CKD + cystitis (7/61; 11%)"/>
 <result pre="and one cat was normotensive. This study strengthens that pre‐renal" exact="proteinuria" post="is rare in cats and CKD is the most"/>
 <result pre="cats and CKD is the most frequent cause of significant" exact="proteinuria" post="in this species. Severe hypertension is a common finding,"/>
 <result pre="suggests that physiological and pre‐renal causes do not induce significant" exact="proteinuria" post="in cats. Disclosures No disclosures to report. ESVNU‐P‐3 The"/>
 <result pre="have evaluated the role of CVBD in the aetiology of" exact="proteinuria" post="in these endemic countries. According to its origin, proteinuria"/>
 <result pre="of proteinuria in these endemic countries. According to its origin," exact="proteinuria" post="can be classified in pre‐renal, renal or post‐renal and"/>
 <result pre="of this study was to assess the main causes of" exact="proteinuria" post="in dogs from the region of Lisbon in order"/>
 <result pre="hospital between January 2017 and December 2018 identified with significant" exact="proteinuria" post="(UPC ratio &amp;gt; 0.5) and with an established primary diagnosis were"/>
 <result pre="Based on the medical records, cases were classified according to" exact="proteinuria" post="origin. 106 dogs were selected. From these, 54% were"/>
 <result pre="had pre‐renal proteinuria, 76% had renal proteinuria, 17% had post‐renal" exact="proteinuria" post="and 7% had a suspected mixed origin (renal+post‐renal). Detailing"/>
 <result pre="(renal+post‐renal). Detailing renal proteinuria, 46% had a presumptive diagnosis of" exact="glomerulonephritis" post="secondary to CVBD, 27% showed chronic kidney disease, 26%"/>
 <result pre="a presumptive diagnosis of glomerulonephritis secondary to CVBD, 27% showed" exact="chronic kidney disease," post="26% had systemic diseases possibly inducing an impaired glomerular"/>
 <result pre="systemic diseases possibly inducing an impaired glomerular permselectivity (bronchopneumonia, enteropathies," exact="liver disease," post="hyperadrenocorticism, diabetes mellitus or neoplasia) and 1% had acute"/>
 <result pre="inducing an impaired glomerular permselectivity (bronchopneumonia, enteropathies, liver disease, hyperadrenocorticism," exact="diabetes mellitus" post="or neoplasia) and 1% had acute kidney injury (AKI)."/>
 <result pre="or neoplasia) and 1% had acute kidney injury (AKI). Post‐renal" exact="proteinuria" post="included dogs with pyometra and urinary tract infection (UTI)."/>
 <result pre="kidney injury (AKI). Post‐renal proteinuria included dogs with pyometra and" exact="urinary tract infection" post="(UTI). Mixed proteinuria was considered in dogs with systemic"/>
 <result pre="included dogs with pyometra and urinary tract infection (UTI). Mixed" exact="proteinuria" post="was considered in dogs with systemic diseases (CVBD, CKD,"/>
 <result pre="3% Babesia canis and 3% Anaplasma spp. Whilst pre‐renal significant" exact="proteinuria" post="was uncommon, CVBD were the main cause of renal"/>
 <result pre="proteinuria was uncommon, CVBD were the main cause of renal" exact="proteinuria" post="in these dogs. Leishmaniosis was the most frequent CVBD"/>
 <result pre="that CVBD are the most common differential diagnosis of renal" exact="proteinuria" post="in dogs from Lisbon. These results might be extrapolated"/>
 <result pre="two types holds a high diagnostic and therapeutic significance. Tubular" exact="proteinuria" post="is defined by the loss of low molecular weight"/>
 <result pre="to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‐PAGE). Solely tubular" exact="proteinuria" post="was considered ‘tubular’, while mixed (tubular and glomerular) and"/>
 <result pre="was considered ‘tubular’, while mixed (tubular and glomerular) and glomerular" exact="proteinuria" post="were considered as ‘non‐tubular’. The median (lower and upper"/>
 <result pre="value was determined to be 0.37, below which the tubular" exact="proteinuria" post="could be identified with high confidence (sensitivity = 93.75%,"/>
 <result pre="negative predictive value = 81.81%). Using this cut‐off value, tubular" exact="proteinuria" post="was diagnosed in 10 dogs (35.71%) and non‐tubular proteinuria"/>
 <result pre="tubular proteinuria was diagnosed in 10 dogs (35.71%) and non‐tubular" exact="proteinuria" post="in 17 animals (60.71%). The uAPR results showed a"/>
 <result pre="NAG index values were found to be 33,12 ± 14,8 U/g. Prolonged" exact="anuria" post="consecutive to uretral obstruction as well as repeated obstructive"/>
 <result pre="Veterinaire Agy, Granges‐Paccot, Switzerland, 3Bessy's Kleintierklinik AG, Regensdorf, Switzerland Reflux" exact="nephropathy" post="is considered a possible cause of end‐stage kidney disease"/>
 <result pre="cause of end‐stage kidney disease in young Boxer dogs. Furthermore," exact="vesicoureteral reflux" post="was found to be associated with urinary tract infection."/>
 <result pre="dogs. Furthermore, vesicoureteral reflux was found to be associated with" exact="urinary tract infection." post="The aim of this study was to evaluate the"/>
 <result pre="in 5% of the culture negative dogs. The combination of" exact="pyuria" post="and bacteria in the sediment was seen in 42%"/>
 <result pre="Boeringer Ingelheim. ESVNU‐P‐7 Evaluation of symmetric dimethylarginine (SDMA) in canine" exact="acute pancreatitis" post="E. Gori, A. Pierini, I. Lippi, V. Meucci, F."/>
 <result pre="Ingelheim. ESVNU‐P‐7 Evaluation of symmetric dimethylarginine (SDMA) in canine acute" exact="pancreatitis" post="E. Gori, A. Pierini, I. Lippi, V. Meucci, F."/>
 <result pre="of this study was to evaluate SDMA in dogs with" exact="acute pancreatitis" post="(AP) and their association with kidney injury and severity"/>
 <result pre="this study was to evaluate SDMA in dogs with acute" exact="pancreatitis" post="(AP) and their association with kidney injury and severity"/>
 <result pre="history of renal diseases (clinical records/history, bloodwork and diagnostic imaging)," exact="urinary tract infection" post="and/or on hemodialysis treatment were excluded, along with dogs"/>
 <result pre="is of limited value as a sole discriminatory test for" exact="urinary tract infection." post="A negative test result does not rule out urinary"/>
 <result pre="tract infection. A negative test result does not rule out" exact="urinary tract infection" post="but may justify withholding of antimicrobial therapy pending the"/>
 <result pre="and its correlation with systemic inflammatory response syndrome (SIRS), and" exact="disseminated intravascular coagulation" post="(DIC). Ten uremic dogs managed with HD (HDG) and"/>
 <result pre="investigations. Disclosures No disclosures to report. ESVNU‐P‐10 Risk factors for" exact="urinary tract infection" post="in dogs with natural occurring leptospirosis: a retrospective cohort"/>
 <result pre="disease. Due to the risk of dog‐to human transmission of" exact="leptospirosis" post="and the need of monitoring urine output in dogs"/>
 <result pre="indwelling urinary catheter during hospitalization. Urinary catheterization can predispose to" exact="urinary tract infection" post="(UTI). The aim of this retrospective cohort study was"/>
 <result pre="to evaluate type and frequency of UTI in dogs with" exact="leptospirosis" post="and to identify risk factors associated with UTI in"/>
 <result pre="searched between January‐2008 and December‐2018 for dogs with diagnosis of" exact="leptospirosis" post="(n = 78). Diagnosis of leptospirosis was consistent clinicopathologic"/>
 <result pre="dogs with diagnosis of leptospirosis (n = 78). Diagnosis of" exact="leptospirosis" post="was consistent clinicopathologic signs, a positive microscopic agglutination test"/>
 <result pre="titer) and/or a positive PCR (urine and/or blood). Dogs with" exact="leptospirosis" post="to be included in the study need to met"/>
 <result pre="Veterinary Specialist, Basildon, United Kingdom Renal damage associated with canine" exact="leishmaniasis" post="induces nephritis and glomerulonephritis which cannot always be detected"/>
 <result pre="Basildon, United Kingdom Renal damage associated with canine leishmaniasis induces" exact="nephritis" post="and glomerulonephritis which cannot always be detected using classical"/>
 <result pre="Kingdom Renal damage associated with canine leishmaniasis induces nephritis and" exact="glomerulonephritis" post="which cannot always be detected using classical laboratorial biomarkers"/>
 <result pre="as early markers of renal disease in dogs affected with" exact="leishmaniasis" post="using a modified IRIS chronic kidney disease staging. A"/>
 <result pre="disease in dogs affected with leishmaniasis using a modified IRIS" exact="chronic kidney disease" post="staging. A prospective study was conducted in 5 groups"/>
 <result pre="is only consistently elevated at more advanced stages of leishmania‐associated" exact="chronic kidney disease." post="Disclosures No disclosures to report. ESVNU‐P‐13 Usefulness of urine"/>
 <result pre="in the diagnosis of renal disease in dogs affected with" exact="leishmaniasis" post="J. Duque 1, P. Charlo 1, B. Macías‐García 1,"/>
 <result pre="Cardiopulmonary Service / Southfields Veterinary Specialist, Basildon, United Kingdom Canine" exact="leishmaniasis" post="is a highly prevalent zoonotic disease in Spain. All"/>
 <result pre="to severely diseased individuals being the clinical signs, creatine and" exact="proteinuria" post="used to assess the evolution of their condition. Evaluation"/>
 <result pre="tubular damage biomarkers such as NGAL and CysC in canine" exact="chronic kidney disease." post="We aimed to evaluate the diagnostic power of urinary"/>
 <result pre="in dogs diagnosed with L. infantum using a modified IRIS" exact="chronic kidney disease" post="staging. Dogs presented to the University of Extremadura veterinary"/>
 <result pre="in 63%; facial swelling, deformation of the nasal planum, and/or" exact="exophthalmos" post="in 20%. Endoscopic examination found neoformation, which was unilateral"/>
 <result pre="No disclosures to report. ESVONC‐P‐2 Sensitivity of canine and human" exact="cancer" post="cell lines towards thermoradiotherapy P.E. Thumser‐Henner 1, K.J. Nytko"/>
 <result pre="of our study were firstly to screen human and canine" exact="cancer" post="cell lines for their sensitivity towards hyperthermia‐radiotherapy treatment, and"/>
 <result pre="treatment were determined in a panel of human and canine" exact="cancer" post="cell lines using a clonogenic survival assay. We analyzed"/>
 <result pre="the major effect of hyperthermia. Interestingly, we discovered a heat‐induced" exact="suppression" post="of BRCA2 transcription, potentially inhibiting the homologous recombination repair"/>
 <result pre="of hepatic infiltration in case of nodal diffuse large B‐cell" exact="lymphoma" post="(DLBLCL) D. Lanore 1, P. Vajdovich 2, J. Borrego"/>
 <result pre="performed for each dog. The ultrasonographic patterns characteristic for canine" exact="lymphoma" post="in liver included coarse parenchyma, ill‐defined hypoechoic areas, hypoechoic"/>
 <result pre="effects of a single dose of vincristine in dogs with" exact="lymphoma" post="A. Mosca, E. Dobson, J. Dobson University of Cambridge,"/>
 <result pre="Hospital, Cambridge, United Kingdom Lymphoma is the most common haematopoetic" exact="neoplasm" post="in the canine population. Chemotherapy protocols, such as COP,"/>
 <result pre="such as COP, CHOP and LOPP are used to treat" exact="lymphoma" post="due to its chemosensitive nature. These protocols routinely involve"/>
 <result pre="single administration. The records of dogs with previously untreated, confirmed" exact="lymphoma" post="receiving vincristine between July 2015 to March 2019 were"/>
 <result pre="was 22.9 kgs ranging from 3.4‐63kgs. Four dogs (9%) experienced" exact="neutropenia" post="(neutrophil count &amp;lt;2.0 x 10^9/L) following a single administration"/>
 <result pre="part of a chemotherapy protocol for lymphoma, developed a significant" exact="neutropenia" post="within one week of vincristine administration. Disclosures No disclosures"/>
 <result pre="in tissues has been associated with tissue damage and especially" exact="glomerulonephritis" post="and renal failure. However, little is known about the"/>
 <result pre="compared with old ones ( P = 0.0451). Young dogs showed" exact="proteinuria" post="less often than older dogs ( P = 0.0029). Dogs"/>
 <result pre="dogs seem to have significantly more tendency to develop ulcerative" exact="dermatitis" post="compared to mixed breed dogs ( P = 0.0460). This"/>
 <result pre="gibsoni and Babesia vogeli have both been identified in canine" exact="babesiosis" post="in Taiwan, where information on the epidemiology of the"/>
 <result pre="relation to the local clinical relevance and treatment of canine" exact="babesiosis" post="in Taiwan. Disclosures No disclosures to report. ISCAID‐P‐5 Risk"/>
 <result pre="parasites prevention, urine color, mucous membrane color and history of" exact="babesiosis" post="were analyzed by using of chi‐square test initially. Variables"/>
 <result pre="parasites and observation of urine color are very important in" exact="babesiosis" post="epidemic areas. Disclosures No disclosures to report. ISCAID‐P‐6 Acantocheilonema"/>
 <result pre="cell count results revealed leukocytosis (n. 16), anaemia (n. 2)," exact="thrombocytopenia" post="(n. 8), eosinophilia (n. 1). Biochemical data showed increased"/>
 <result pre="revealed leukocytosis (n. 16), anaemia (n. 2), thrombocytopenia (n. 8)," exact="eosinophilia" post="(n. 1). Biochemical data showed increased serum values of"/>
 <result pre="the existence of the disease are controversially discussed. Fever and" exact="arthritis" post="are clinical manifestations most often associated with LB; other"/>
 <result pre="four cases (14%); one dog (3%) died of a dilated" exact="cardiomyopathy" post="and one suspicious dog presented barking troubles that responded"/>
 <result pre="as the dog with cardiac presentation and 3/4 cases with" exact="kidney failure" post="died. Application of parasiticides was not always recorded; 6/29"/>
 <result pre="(CMhp) are two species of canine hemoplasma that may cause" exact="hemolytic anemia" post="and chronic disease in canine species. While understanding is"/>
 <result pre="are two species of canine hemoplasma that may cause hemolytic" exact="anemia" post="and chronic disease in canine species. While understanding is"/>
 <result pre="Infiniti Medical, LLC. ISCAID‐P‐11 Retrospective analysis of cases tested for" exact="leptospirosis" post="at a university teaching hospital H.K. Walker, N.X. Bommer,"/>
 <result pre="There is very little published data on positive cases of" exact="leptospirosis" post="seen in veterinary practice in the United Kingdom. This"/>
 <result pre="Kingdom. This study aims to analyze all cases tested for" exact="leptospirosis" post="in a UK university teaching hospital between 2011 and"/>
 <result pre="from a university database; all dogs that were screened for" exact="leptospirosis" post="via urine PCR, blood PCR, or serum MAT were"/>
 <result pre="the positive cases presented with pulmonary haemorrhage or dyspnea. Primary" exact="leptospirosis" post="was the final diagnosis for 27 of the 39"/>
 <result pre="diagnosis (neoplasia (n = 3); biliary mucocele (n = 1);" exact="necrotizing fasciitis" post="(n = 1); pericardial effusion (n = 1)). Three"/>
 <result pre="(neoplasia (n = 3); biliary mucocele (n = 1); necrotizing" exact="fasciitis" post="(n = 1); pericardial effusion (n = 1)). Three"/>
 <result pre="biliary mucocele (n = 1); necrotizing fasciitis (n = 1);" exact="pericardial effusion" post="(n = 1)). Three of the positive cases had"/>
 <result pre="non‐enhancing central scar was observed within this lesion. A hepatocellular" exact="adenoma" post="was diagnosed in two cases. The lesions were T1‐W"/>
 <result pre="centre in T2‐W images. No contrast enhancement was noted. A" exact="hepatocellular carcinoma" post="was also diagnosed in one case. This lesion was"/>
</results>
